Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 45 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well as academia covering the following hot topics:

R&D STRATEGIES & BUSINESS MODELS AND PHARMA/BIOTECH ALLIANCES COLLABORATIONS–Challenges and strategies to enhance productivity in drug discovery such as open innovation, innovative business models, lean thinking and the benefits of industry and academic alliances

MEDICINAL CHEMISTRY / DRUG DESIGN –Reducing attrition in development, fragment based techniques, flow chemistry, reducing risk of toxicity, structure based discovery as well as hit identification strategies

SCREENING TECHNIQUES & ASSAY DEVELOPMENT – Improving quality of assays, compound selection, target selection and validation, as well as cost effective lead identification Initiatives for HTS, HCS and label free as well as the potential of pluripotent stem cells

BIOMARKERS & PERSONALISED / TRANSLATIONAL MEDICINE –Translational medicine and diagnostic case studies as well as how Biomarkers facilitate early decision making in early development

BIOINFORMATICS  –Systems biology, computational modelling, ADMET & PK/ PD modelling as well as knowledge management and data intergration tools in Drug Safety

BIOLOGICS – Strategies to integrate biologics into an organisation, including presentations in phage display in peptides, a panel discussion on biobetters, case study on pepducins